🇺🇸 FDA
Pipeline program

CAIV-T

D153-P522

Phase 2 mab completed

Quick answer

CAIV-T for Influenza is a Phase 2 program (mab) at MedImmune with 1 ClinicalTrials.gov record(s).

Program details

Company
MedImmune
Indication
Influenza
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials